EU Bone Replacement Market Projected to Reach over $264MM by 2016
IRVINE, Calif.--(BUSINESS WIRE)-- BioMedGPS, LLC, the leading provider of real-time business intelligence and competitive metrics for life science companies, introduces its newest market overview EU Bone Replacement expanding OUS coverage of SmartTRAK Business Intelligence Hub™. BioMedGPS projects robust 5-year growth in the EU market for bone replacement products reaching over €203MM (US$264MM) in 2016. SmartTRAK Business Intelligence Hub™ provides in-depth analysis and deep industry content on the companies, products, and market drivers impacting this segment—delivered on a versatile digital platform networking an enterprise with real-time information.
“Usage of bone replacement products not only differs between the US and EU but also among EU countries,” reports Sharon O’Reilly, President and CEO of BioMedGPS. “For example, human-derived products—demineralized bone matrix, structural allografts and stem cells—are widely used in the US whereas synthetics are favored among EU surgeons owing to attitudes toward cadaver tissue in some countries. Spine is typically the largest application for bone replacement products, but in Germany where products are not reimbursed for fusion, the largest application is trauma.”
BioMedGPS analysts—all former competitive intelligence specialists at major orthopedic and spine companies— monitor more than 120 companies and 300 bone replacement products world-wide making SmartTRAK Bone Module the most comprehensive source for up-to-date information on the competitors, emerging products and market developments in this crowded market.
Currently available SmartTRAK modules include:
- Extremities (Foot & Ankle, Wrist & Hand, Shoulder)
- Spine (Fusion, Motion, Spinous Process Implants, VCF)
- Wound Biologics
This fall, BioMedGPS will be launching SmartTRAK modules for:
- Hip and Knee Replacement
- Sports Medicine Fixation
- Advanced Dressings, Negative Pressure Wound Therapy
SmartTRAK transforms business intelligence into an accessible enterprise-wide process, gives companies power to upload and share their insights onto the platform securely, and provides powerful tools facilitating strategic analysis. See what subscribers have to say about SmartTRAK by visiting http://biomedgps.com/intro.
About BioMedGPS, LLC
BioMedGPS, LLC provides online business intelligence and dynamic decision-making tools specifically for life science executives. BioMedGPS is led by Sharon O’Reilly, founder and former President & CEO of Medtech Insight.
To learn more about BioMedGPS, please visit http://www.biomedgps.com.
Source: BioMedGPS, LLC